01 1SENTYNL THERAPS INC
01 17504095
01 1Blank
01 1Y
01 12025-01-31
Patent Expiration Date : 2025-01-31
US Patent Number : 7504095
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214018
Patent Use Code : U-3092
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-01-31
LOOKING FOR A SUPPLIER?